Open-label Extension Study to Evaluate the Long-term Safety of Cenobamate Adjunctive Therapy in Subjects with Primary Generalized Tonic- Clonic Seizures

Open-label Extension Study to Evaluate the Long-term Safety of Cenobamate Adjunctive Therapy in Subjects with Primary Generalized Tonic- Clonic Seizures
Enrolling By Invitation
18 years - 99 years
All
Phase 3
10 participants needed
1 Location

Brief description of study

The research study is being conducted to evaluate the long-term safety and tolerability of cenobamate for Primary Generalized Tonic-Clonic (PGTC) seizures

Detailed description of study

 You are being invited to participate in this study because you have completed main study YKP3089C025.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: epilepsy,seizures
  • Age: 18 years - 99 years
  • Gender: All


Updated on 19 Feb 2024. Study ID: 834015
If you need help finding a study or have any questions, please contact us at psom-ocr@pobox.upenn.edu

 

Interested in the study?

Message For Enrolling By Invitation Trial

study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact a study center.